ACETAZOLAMIDE SODIUM

Post-LOE

acetazolamide

ANDAINJECTIONINJECTABLE
Approved
Feb 1995
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

CLINICAL PHARMACOLOGY Acetazolamide for Injection is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e.g., some types of glaucoma), in the treatment of certain convulsive disorders (e.g., epilepsy) and in the promotion of diuresis in instances of abnormal fluid…

Indications (2)

Clinical Trials (5)

NCT06776432Phase 2Recruiting

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

Started Apr 2025
NCT06498505Phase 4Recruiting

HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men

Started Jul 2024
270 enrolled
High Altitude
NCT06499727Phase 4Completed

HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men

Started Jul 2024
303 enrolled
Acute Mountain Sickness
NCT06498531Phase 4Recruiting

HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men

Started Jul 2024
270 enrolled
Sleep-Disordered Breathing
NCT03525561Phase 1Completed

Acetazolamide and Exercise Performance at Altitude

Started Oct 2018
10 enrolled
HypoxiaExercise PerformanceCognitive Function+1 more